SCHEMBL10200470

SCHEMBL10200470

Nc1cc(-c2ccc(O)c(I)c2)n[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.42
ALPL P05186 2/20 0.37
MAPT P10636 7/20 0.36
HPGD P15428 6/20 0.36
KMT2A Q03164 6/20 0.36
ALOX15 P16050 6/20 0.36
LMNA P02545 5/20 0.36
MEN1 O00255 5/20 0.36
NPSR1 Q6W5P4 5/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MAPK1 P28482 3/20 0.36
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.36
TP53 P04637 1/20 0.36
GLA P06280 1/20 0.36
ALOX5 P09917 1/20 0.36
ALOX12 P18054 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7934973 0.83 APP (0.44) APPALPLMAPTHPGDKMT2A
SCHEMBL18966078 0.77 METAP2 (0.46) ALPLMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL10200469 0.76 MAPT (0.46) APPMAPTHPGDKMT2AALOX15
SCHEMBL10200379 0.72 APP (0.34) APPMAPTHPGDKMT2AALOX15
SCHEMBL28466328 0.72 ALPL (0.58) ALPLMAPTHPGDKMT2ALMNA
SCHEMBL4086117 0.71 HSD17B1 (0.50) ALPLMAPTHPGDKMT2AALOX15
SCHEMBL19880348 0.71 APP (0.55) APPMAPTHPGDKMT2AALOX15
Hydrochloric Acid SCHEMBL9124767 0.71 ALPL (0.56) ALPLMAPTHPGDKMT2ALMNA
SCHEMBL14731247 0.70 HPGD (0.54) MAPTHPGDKMT2ALMNANPSR1
SCHEMBL15656631 0.70 NOTUM (0.44) ALPLMAPTLMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8569336-B2 Compounds for the treatment of inflammatory disorders TONG LING (US) 2013-10-29 US disclosed
US-8569336-B2 Compounds for the treatment of inflammatory disorders TONG LING (US) 2013-10-29 US disclosed
US-20120015926-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS TONG LING (US) 2012-01-19 US disclosed
US-20120015926-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS TONG LING (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015926-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS TNF, ADAMTS1, ADAMTS7 APP 236/4885ALPL 323/4885MAPT 971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.